Drug Delivery Matrix Containing Native Protein Precipitates Suspended in a Poloxamer Gel
- 1 September 1997
- journal article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 86 (9) , 1006-1010
- https://doi.org/10.1021/js970034d
Abstract
Sustained delivery systems can achieve more constant blood levels of protein therapeutics than those obtained with bolus doses, leading to improved drug efficacy and fewer adverse side effects. Several different polymeric delivery systems have been studied, including poloxamers, which are unique because they can be prepared in aqueous buffers that are compatible with proteins. Poloxamers are nontoxic block copolymers of poly(ethylene oxide) and poly(propylene oxide). Certain poloxamers exhibit reversible thermal gelation. Thus, a solution of protein and poloxamer prepared at low temperatures and injected extravascularly will form a gel as it warms to body temperature. Subsequently, the protein is released slowly from the gel. To date, however, poloxamer gel delivery systems have been limited to relatively low protein concentrations (i.e., < or = 0.4 mg/mL) that produce a completely soluble protein and an optically clear gel. Much higher concentrations of other protein drugs might be needed to obtain an efficacious sustained dose. In the current in vitro study we found that a poloxamer 407 (22% wt/wt) matrix could be prepared containing tens of milligrams/mililiter of the model proteins alpha-chymotrypsin and lactate dehydrogenase. Under these conditions the protein forms a homogeneous suspension. Warming through the poloxamer 407 transition temperature (ca. 18 degrees C) results in a gel that retains a homogeneous distribution of protein precipitates for several days at 37 degrees C. Infrared spectroscopy documented that the precipitated proteins in the suspension have native secondary structure. Furthermore, the fully active protein can be recovered completely when the gel is dissolved in excess buffer. Finally, at the higher protein concentrations used to form the suspensions in poloxamer 407, protein stability during incubation at 37 degrees C was greatly improved over that seen at lower protein concentrations.Keywords
This publication has 15 references indexed in Scilit:
- Counteracting effects of thiocyanate and sucrose on chymotrypsinogen secondary structure and aggregation during freezing, drying, and rehydrationBiophysical Journal, 1996
- Polymers Protect Lactate Dehydrogenase during Freeze-Drying by Inhibiting Dissociation in the Frozen StateArchives of Biochemistry and Biophysics, 1996
- Sustained-release interleukin-2 following intramuscular injection in ratsInternational Journal of Pharmaceutics, 1995
- Formulation and Delivery of Proteins and PeptidesPublished by American Chemical Society (ACS) ,1994
- [9] Infrared methods for study of hemoglobin reactions and structuresPublished by Elsevier ,1994
- Biological Activity of Urease Formulated in Poloxamer 407 after Intraperitoneal Injection in the RatJournal of Pharmaceutical Sciences, 1992
- Sustained Delivery of Interleukin-2 from a Poloxamer 407 Gel Matrix Following Intraperitoneal Injection in MicePharmaceutical Research, 1992
- An Automated Temperature Control and Data Acquisition System for Fourier Transform Infrared Studies: Application to Phase Changes in Hydrocarbons and Lipid BilayersApplied Spectroscopy, 1987
- Characterization by infrared spectroscopy of the bilayer to nonbilayer phase transition of phosphatidylethanolaminesBiochemistry, 1981
- A sensitive new substrate for chymotrypsinAnalytical Biochemistry, 1979